Laura Duffy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Duffy has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso Iorio
Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada
2 shared publications - Ana Marušić
Department of Research, University Hospital of Split, Spinčićeva 1, 21000 Split, Croatia
2 shared publications - Cynthia Lokker
Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada
2 shared publications - Daivat Bhavsar
Institute of General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany
2 shared publications - Hamin Jo
Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada
2 shared publications - Jeremy Yongwen Ng
Institute of General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany
2 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 3036
Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype
The role of the cohesin complex depends on the cohesin loader proteins NIPBL and MAU2. While NIPBL variants are a major cause of Cornelia de Lange Syndrome (CdLS), the role of MAU2 in disease is unclear. We describe 18 individuals carrying 15 heterozygous MAU2 variants and demonstrate pathogenicity through functional analyses. In-frame MAU2 variants predominantly impair NIPBL–MAU2 interaction, whereas truncating variants cause MAU2 haploinsufficiency and lead to NIPBL reduction. Most individuals exhibit a DNA methylation profile compatible with the CdLS episignature. We also describe two MAU2 -specific episignatures that reflect variant-dependent molecular consequences. Affected individuals display a wide range of phenotypes, from classic CdLS to milder presentations, with short stature and microcephaly as major features. A heterozygous Mau2 knockout mouse model recapitulates these traits, confirming the causal role of MAU2 disruption in vivo. Our study establishes MAU2 as a CdLS-associated gene and delineates a MAU2 -related chromatinopathy with variable expressivity.
- 30 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 3036
Open AccessPathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype
The role of the cohesin complex depends on the cohesin loader proteins NIPBL and MAU2. While NIPBL variants are a major cause of Cornelia de Lange Syndrome (CdLS), the role of MAU2 in disease is unclear. We describe 18 individuals carrying 15 heterozygous MAU2 variants and demonstrate pathogenicity through functional analyses. In-frame MAU2 variants predominantly impair NIPBL–MAU2 interaction, whereas truncating variants cause MAU2 haploinsufficiency and lead to NIPBL reduction. Most individuals exhibit a DNA methylation profile compatible with the CdLS episignature. We also describe two MAU2 -specific episignatures that reflect variant-dependent molecular consequences. Affected individuals display a wide range of phenotypes, from classic CdLS to milder presentations, with short stature and microcephaly as major features. A heterozygous Mau2 knockout mouse model recapitulates these traits, confirming the causal role of MAU2 disruption in vivo. Our study establishes MAU2 as a CdLS-associated gene and delineates a MAU2 -related chromatinopathy with variable expressivity.
- Top Cited PapersOpen Access
- 28 February 2025
- Published by Springer Nature in Research Integrity and Peer Review
- Vol. 10 (1) , 1-12
Policies on artificial intelligence chatbots among academic publishers: a cross-sectional audit
Background: Artificial intelligence (AI) chatbots are novel computer programs that can generate text or content in a natural language format. Academic publishers are adapting to the transformative role of AI chatbots in producing or facilitating scientific research. This study aimed to examine the policies established by scientific, technical, and medical academic publishers for defining and regulating the authors’ responsible use of AI chatbots. Methods: This study performed a cross-sectional audit on the publicly available policies of 162 academic publishers, indexed as members of the International Association of the Scientific, Technical, and Medical Publishers (STM). Data extraction of publicly available policies on the webpages of all STM academic publishers was performed independently, in duplicate, with content analysis reviewed by a third contributor (September 2023—December 2023). Data was categorized into policy elements, such as ‘proofreading’ and ‘image generation’. Counts and percentages of ‘yes’ (i.e., permitted), ‘no’, and ‘no available information’ (NAI) were established for each policy element. Results: A total of 56/162 (34.6%) STM academic publishers had a publicly available policy guiding the authors’ use of AI chatbots. No policy allowed authorship for AI chatbots (or other AI tool). Most (49/56 or 87.5%) required specific disclosure of AI chatbot use. Four policies/publishers placed a complete ban on the use of AI chatbots by authors. Conclusions: Only a third of STM academic publishers had publicly available policies as of December 2023. A re-examination of all STM members in 12–18 months may uncover evolving approaches toward AI chatbot use with more academic publishers having a policy.
- 28 February 2025
- Published by Springer Nature in Research Integrity and Peer Review
- Vol. 10 (1) , 1-12
Top Cited PapersOpen AccessPolicies on artificial intelligence chatbots among academic publishers: a cross-sectional audit
Background: Artificial intelligence (AI) chatbots are novel computer programs that can generate text or content in a natural language format. Academic publishers are adapting to the transformative role of AI chatbots in producing or facilitating scientific research. This study aimed to examine the policies established by scientific, technical, and medical academic publishers for defining and regulating the authors’ responsible use of AI chatbots. Methods: This study performed a cross-sectional audit on the publicly available policies of 162 academic publishers, indexed as members of the International Association of the Scientific, Technical, and Medical Publishers (STM). Data extraction of publicly available policies on the webpages of all STM academic publishers was performed independently, in duplicate, with content analysis reviewed by a third contributor (September 2023—December 2023). Data was categorized into policy elements, such as ‘proofreading’ and ‘image generation’. Counts and percentages of ‘yes’ (i.e., permitted), ‘no’, and ‘no available information’ (NAI) were established for each policy element. Results: A total of 56/162 (34.6%) STM academic publishers had a publicly available policy guiding the authors’ use of AI chatbots. No policy allowed authorship for AI chatbots (or other AI tool). Most (49/56 or 87.5%) required specific disclosure of AI chatbot use. Four policies/publishers placed a complete ban on the use of AI chatbots by authors. Conclusions: Only a third of STM academic publishers had publicly available policies as of December 2023. A re-examination of all STM members in 12–18 months may uncover evolving approaches toward AI chatbot use with more academic publishers having a policy.
- Open Access
Policies on Artificial Intelligence Chatbots Among Academic Publishers: A Cross-Sectional Audit
Background Artificial intelligence (AI) chatbots are novel computer programs that can generate text or content in a natural language format. Academic publishers are adapting to the transformative role of AI chatbots in producing or facilitating scientific research. This study aimed to examine the policies established by scientific, technical, and medical academic publishers for defining and regulating the responsible authors’ use of AI chatbots. Methods This study performed a cross-sectional audit on the publicly available policies of 163 academic publishers, indexed as members of the International Association of the Scientific, Technical, and Medical Publishers (STM). Data extraction of publicly available policies on the webpages of all STM academic publishers was performed independently in duplicate with content analysis reviewed by a third contributor (September 2023 - December 2023). Data was categorized into policy elements, such as ‘proofreading’ and ‘image generation’. Counts and percentages of ‘yes’ (i.e., permitted), ‘no’, and ‘N/A’ were established for each policy element. Results A total of 56/163 (34.4%) STM academic publishers had a publicly available policy guiding the authors’ use of AI chatbots. No policy allowed authorship accreditations for AI chatbots (or other generative technology). Most (49/56 or 87.5%) required specific disclosure of AI chatbot use. Four policies/publishers placed a complete ban on the use of AI tools by authors. Conclusions Only a third of STM academic publishers had publicly available policies as of December 2023. A re-examination of all STM members in 12-18 months may uncover evolving approaches toward AI chatbot use with more academic publishers having a policy.
Open AccessPolicies on Artificial Intelligence Chatbots Among Academic Publishers: A Cross-Sectional Audit
Background Artificial intelligence (AI) chatbots are novel computer programs that can generate text or content in a natural language format. Academic publishers are adapting to the transformative role of AI chatbots in producing or facilitating scientific research. This study aimed to examine the policies established by scientific, technical, and medical academic publishers for defining and regulating the responsible authors’ use of AI chatbots. Methods This study performed a cross-sectional audit on the publicly available policies of 163 academic publishers, indexed as members of the International Association of the Scientific, Technical, and Medical Publishers (STM). Data extraction of publicly available policies on the webpages of all STM academic publishers was performed independently in duplicate with content analysis reviewed by a third contributor (September 2023 - December 2023). Data was categorized into policy elements, such as ‘proofreading’ and ‘image generation’. Counts and percentages of ‘yes’ (i.e., permitted), ‘no’, and ‘N/A’ were established for each policy element. Results A total of 56/163 (34.4%) STM academic publishers had a publicly available policy guiding the authors’ use of AI chatbots. No policy allowed authorship accreditations for AI chatbots (or other generative technology). Most (49/56 or 87.5%) required specific disclosure of AI chatbot use. Four policies/publishers placed a complete ban on the use of AI tools by authors. Conclusions Only a third of STM academic publishers had publicly available policies as of December 2023. A re-examination of all STM members in 12-18 months may uncover evolving approaches toward AI chatbot use with more academic publishers having a policy.